Hidalgo-Lozada, G.M.; Villarruel-López, A.; MartÃnez-Abundis, E.; Vázquez-Paulino, O.; González-Ortiz, M.; Pérez-Rubio, K.G.
Ellagic Acid Effect on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. J. Clin. Med. 2022, 11, 5741.
https://doi.org/10.3390/jcm11195741
AMA Style
Hidalgo-Lozada GM, Villarruel-López A, MartÃnez-Abundis E, Vázquez-Paulino O, González-Ortiz M, Pérez-Rubio KG.
Ellagic Acid Effect on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Journal of Clinical Medicine. 2022; 11(19):5741.
https://doi.org/10.3390/jcm11195741
Chicago/Turabian Style
Hidalgo-Lozada, Gladys Maribel, Angélica Villarruel-López, Esperanza MartÃnez-Abundis, Olga Vázquez-Paulino, Manuel González-Ortiz, and Karina Griselda Pérez-Rubio.
2022. "Ellagic Acid Effect on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial" Journal of Clinical Medicine 11, no. 19: 5741.
https://doi.org/10.3390/jcm11195741
APA Style
Hidalgo-Lozada, G. M., Villarruel-López, A., MartÃnez-Abundis, E., Vázquez-Paulino, O., González-Ortiz, M., & Pérez-Rubio, K. G.
(2022). Ellagic Acid Effect on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Journal of Clinical Medicine, 11(19), 5741.
https://doi.org/10.3390/jcm11195741
